A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy Participants
Clinical trial NCT04489797 · COMPLETED
Trial details
- NCT number
- NCT04489797
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2020-08-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.